Tevogen Bio/$TVGN
1D1W1MYTD1Y5YMAX
Capital at risk
About Tevogen Bio
Tevogen Inc is a healthcare enterprise engaged in biotechnology, artificial intelligence and technology, and healthcare services. Its operations focus on the development of biotechnology products, AI- and technology-based healthcare solutions, and healthcare service initiatives.
- Ticker
- $TVGN
- Sector
- Health
- Primary listing
- NASDAQ
- Employees
- -
- Headquarters
- Warren, United States
- Website
- tevogen.com
Tevogen Bio Metrics
BasicAdvanced
$51M
-
-$6.32
0.20
-
Price and volume
Market cap
$51M
Beta
0.2
52-week high
$12.03
52-week low
$3.64
Average daily volume
8.4K
Financial strength
Current ratio
0.327
Quick ratio
0.202
Long term debt to equity
-0.84
Total debt to equity
-1.062
Interest coverage (TTM)
-70.74%
Profitability
EBITDA (TTM)
-21.284
Management effectiveness
Return on assets (TTM)
-297.37%
Return on equity (TTM)
235.26%
Valuation
Price to book
-1.88
Price to tangible book (TTM)
-1.88
Price to free cash flow (TTM)
-2.362
Free cash flow yield (TTM)
-42.34%
Free cash flow per share (TTM)
-3.307
Growth
Earnings per share change (TTM)
-37.58%
3-year earnings per share growth (CAGR)
-47.56%
Upcoming events
No upcoming events
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.